Identification of a Notch transcriptomic signature for breast cancer

被引:1
|
作者
Braune, Eike-Benjamin [1 ]
Geist, Felix [2 ]
Tang, Xiaojia [3 ]
Kalari, Krishna [3 ]
Boughey, Judy [4 ]
Wang, Liewei [5 ]
Leon-Ferre, Roberto A. [6 ]
D'Assoro, Antonino B. [6 ]
Ingle, James N. [6 ]
Goetz, Matthew P. [5 ,6 ]
Kreis, Julian [2 ]
Wang, Kang [7 ]
Foukakis, Theodoros [7 ]
Seshire, Anita [8 ]
Wienke, Dirk [2 ]
Lendahl, Urban [1 ]
机构
[1] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden
[2] Merck Healthcare KGaA, Darmstadt, Germany
[3] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[4] Mayo Clin, Dept Surg, Rochester, MN USA
[5] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
[6] Mayo Clin, Dept Oncol, Rochester, MN USA
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Merck KGaA, Darmstadt, Germany
关键词
Breast cancer; Basal-like; Breast cancer stem cell; Notch signalling; Transcriptomic signature; Therapy; Therapy resistance; Triple-negative; Diagnostics; GENE-EXPRESSION SIGNATURE; TUMOR-INITIATING CELLS; SIGNALING PATHWAY; ESTROGEN-RECEPTOR; C-MYC; MAMMARY; DIFFERENTIATION; PROMOTES; TARGET; GROWTH;
D O I
10.1186/s13058-023-01757-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundDysregulated Notch signalling contributes to breast cancer development and progression, but validated tools to measure the level of Notch signalling in breast cancer subtypes and in response to systemic therapy are largely lacking. A transcriptomic signature of Notch signalling would be warranted, for example to monitor the effects of future Notch-targeting therapies and to learn whether altered Notch signalling is an off-target effect of current breast cancer therapies. In this report, we have established such a classifier.MethodsTo generate the signature, we first identified Notch-regulated genes from six basal-like breast cancer cell lines subjected to elevated or reduced Notch signalling by culturing on immobilized Notch ligand Jagged1 or blockade of Notch by gamma-secretase inhibitors, respectively. From this cadre of Notch-regulated genes, we developed candidate transcriptomic signatures that were trained on a breast cancer patient dataset (the TCGA-BRCA cohort) and a broader breast cancer cell line cohort and sought to validate in independent datasets.ResultsAn optimal 20-gene transcriptomic signature was selected. We validated the signature on two independent patient datasets (METABRIC and Oslo2), and it showed an improved coherence score and tumour specificity compared with previously published signatures. Furthermore, the signature score was particularly high for basal-like breast cancer, indicating an enhanced level of Notch signalling in this subtype. The signature score was increased after neoadjuvant treatment in the PROMIX and BEAUTY patient cohorts, and a lower signature score generally correlated with better clinical outcome.ConclusionsThe 20-gene transcriptional signature will be a valuable tool to evaluate the response of future Notch-targeting therapies for breast cancer, to learn about potential effects on Notch signalling from conventional breast cancer therapies and to better stratify patients for therapy considerations.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Identification of a Notch transcriptomic signature for breast cancer
    Braune, Eike-Benjamin
    Geist, Felix
    Tang, Xiaojia
    Kalari, Krishna
    Boughey, Judy
    Wang, Liewei
    Leon-Ferre, Roberto A.
    D'Assoro, Antonino B.
    Ingle, James N.
    Goetz, Matthew P.
    Wang, Kang
    Foukakis, Theodoros
    Seshire, Anita
    Wienke, Dirk
    Lendahl, Urban
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [2] Identification of a Notch transcriptomic signature for breast cancer
    Eike-Benjamin Braune
    Felix Geist
    Xiaojia Tang
    Krishna Kalari
    Judy Boughey
    Liewei Wang
    Roberto A. Leon-Ferre
    Antonino B. D’Assoro
    James N. Ingle
    Matthew P. Goetz
    Julian Kreis
    Kang Wang
    Theodoros Foukakis
    Anita Seshire
    Dirk Wienke
    Urban Lendahl
    [J]. Breast Cancer Research, 26
  • [3] Identification of a NOTCH transcriptomic signature for basal-like breast cancer
    Braune, Eike-Benjamin
    Geist, Felix
    Wienke, Dirk
    Seshire, Anita
    Lendahl, Urban
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [4] A functional Notch–survivin gene signature in basal breast cancer
    Connie W Lee
    Karl Simin
    Qin Liu
    Janet Plescia
    Minakshi Guha
    Ashraf Khan
    Chung-Cheng Hsieh
    Dario C Altieri
    [J]. Breast Cancer Research, 10
  • [5] Transcriptomic mapping on Notch signaling in A luminal phenotype breast cancer.
    Ingrid Rojas, Katerin
    Rocio Martin, M.
    Rojo, Federico
    Gamez-Pozo, Angelo
    De Castro, Francisco J.
    Filipovich, Elena
    Ceballos, Jaime
    Rosario Hernandez, M.
    Ales-Martinez, Jose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] In silico transcriptomic mapping of Notch biological pathway in luminal breast cancer
    Rojas Laimito, K. I.
    Martin, M. R.
    Rojo, F.
    Gamez-Pozo, A.
    De Castro, F. J.
    Filipovich Vegas, E.
    Ceballos Viro, J.
    Ales Martinez, J. E.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (08) : S1397 - S1397
  • [7] A functional Notch-survivin gene signature in basal breast cancer
    Lee, Connie W.
    Simin, Karl
    Liu, Qin
    Plescia, Janet
    Guha, Minakshi
    Khan, Ashraf
    Hsieh, Chung-Cheng
    Altieri, Dario C.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (06)
  • [8] Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis
    Chen, Chao
    Lin, Cai-Jin
    Li, Si-Yuan
    Hu, Xin
    Shao, Zhi-Ming
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (20)
  • [9] Identification and Validation of a Metastasis Signature in Human Breast Cancer
    Zhao, S.
    Speers, C.
    Shillkrut, M.
    Liu, M.
    Pierce, L. J.
    Feng, F. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S823 - S823
  • [10] Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer
    Iwona Sidorkiewicz
    Maciej Jóźwik
    Angelika Buczyńska
    Anna Erol
    Marcin Jóźwik
    Marcin Moniuszko
    Katarzyna Jarząbek
    Magdalena Niemira
    Adam Krętowski
    [J]. Scientific Reports, 13